|
| Press Releases |
|
 |
|
| Tuesday, August 13, 2013 |
|
|
New Strategy to Disarm the Dengue Virus Brings New Hope for a Universal Dengue Vaccine |
| A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR's Singapore Immunology Network (SIgN). more info >> |
|
| Tuesday, August 6, 2013 |
|
|
Unexpected Synergy Between Two Cancer-linked Proteins Offers Hope for Personalised Cancer Therapy |
| A team of scientists led by Associate Professor Zeng Qi from A*STAR's Institute of Molecular and Cell Biology (IMCB) have discovered a new biomarker which will help physicians predict how well cancer patients respond to cancer drugs. more info >> |
|
| Saturday, July 27, 2013 |
|
|
Singapore Scientists Discover New Drug Targets for Aggressive Breast Cancer |
Scientists at A*STAR's Genome Institute of Singapore (GIS) led in a study that has identified genes that are potential targets for therapeutic drugs against aggressive breast cancer. These findings were reported in the July 2013 issue of PNAS.
more info >> |
|
| Tuesday, July 2, 2013 |
|
|
Genome Institute of Singapore Scientists Discover Molecular Communication Network in Human Stem Cells |
| Scientists at A*STAR's Genome Institute of Singapore (GIS) and the Max Planck Institute for Molecular Genetics (MPIMG) in Berlin (Germany) have discovered a molecular network in human embryonic stem cells (hESCs) that integrates cell communication signals to keep the cell in its stem cell state. These findings were reported in the June 2013 issue of Molecular Cell. more info >> |
|
| Friday, May 17, 2013 |
|
|
A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing |
| Singapore's Agency for Science, Technology and Research (A*STAR) and Switzerland's Cytos Biotechnology AG today announced that the first healthy volunteer has been dosed in a Phase 1 clinical trial with their H1N1 influenza vaccine candidate based on Cytos' proprietary bacteriophage Qbeta virus-like particle (VLP) technology. more info >> |
|
| Thursday, April 25, 2013 |
|
|
A*STAR and Veredus Laboratories Create Market's First Lab-on-Chip for the Detection of Multiple Tropical Infectious Diseases |
| The Agency for Science, Technology and Research (A*STAR) and Veredus Laboratories, a leading supplier of innovative molecular diagnostic tools, announced the launch of VereTrop(TM), the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases from a single blood sample. more info >> |
|
| Monday, April 22, 2013 |
|
|
Understanding Abnormal Proteins in Degenerative Diseases |
| Now, a new class of ultrasmall peptides developed by the Institute of Bioengineering and Nanotechnology (IBN) offers scientists a platform for understanding abnormal proteins, providing them with the insights required to design more effective treatments for degenerative diseases such as Alzheimer's, diabetes and cancer. more info >> |
|
| Thursday, April 18, 2013 |
|
|
Singapore Scientist Wins Coveted Chen New Investigator Award 2013 |
| Dr Patrick Tan from A*STAR's Genome Institute of Singapore (GIS) has received the 2013 Chen New Investigator Award from the international Human Genome Organisation (HUGO). more info >> |
|
|
A*STAR Scientists Decipher Genome Code of a Living Fossil |
| An enigmatic prehistoric fish has brought scientists at A*STAR's Institute of Molecular and Cell Biology (IMCB) together with researchers from all over the world to crack its genomic code. Findings from the study are providing new insights into the evolutionary history of the African coelacanth and possible clues as to how aquatic creatures transitioned to life on land. more info >> |
|
| Friday, April 5, 2013 |
|
|
A*STAR Scientist Alex Matter Awarded Prestigious Szent-Gyorgyi Prize For Progress In Cancer Research |
| Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gyorgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
韓国の主要人物・金載德氏がMOVA Chain支援を表明、エコシステム発展が新段階へ
Dec 13, 2025 13:00: JST
|
|
|
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Dec 12, 2025 23:15 JST
|
|
|
京東工業登陸港交所：業績與品牌雙賦能 長期成長潛力可期
Dec 12, 2025 17:05 HKT/SGT
|
|
|
京东工业登陆港交所：业绩与品牌双赋能 长期成长潜力可期
Dec 12, 2025 17:04 HKT/SGT
|
|
|
京東工業配售結果出爐：MRO龍頭實力領跑 全鏈條數智化解決方案釋放長期價值
Dec 12, 2025 17:00 HKT/SGT
|
|
|
京东工业配售结果出炉：MRO龙头实力领跑 全链条数智化解决方案释放长期价值
Dec 12, 2025 17:00 HKT/SGT
|
|
|
全鏈條服務+業績高增長彰顯實力 京東工業港交所上市釋放長期價值
Dec 12, 2025 15:54 HKT/SGT
|
|
|
全链条服务+业绩高增长彰显实力 京东工业港交所上市释放长期价值
Dec 12, 2025 15:54 HKT/SGT
|
|
|
首隻山水實景表演概念股 印象大紅袍啟動香港公開募股
Dec 12, 2025 15:01 HKT/SGT
|
|
|
首只山水实景表演概念股 印象大红袍启动香港公开募股
Dec 12, 2025 15:00 HKT/SGT
|
|
|
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
Dec 12, 2025 14:35 HKT/SGT
|
|
|
雲頂新耀與海森生物簽署商業化服務協議及授權許可協議 推動商業化協同與多領域佈局
Dec 12, 2025 14:35 HKT/SGT
|
|
|
云顶新耀与海森生物签署商业化服务协议及授权许可协议 推动商业化协同与多领域布局
Dec 12, 2025 14:35 HKT/SGT
|
|
|
國泰海通成功發行非銀金融機構首單上海自貿離岸債
Dec 12, 2025 11:41 HKT/SGT
|
|
|
国泰海通成功发行非银金融机构首单上海自贸离岸债
Dec 12, 2025 11:41 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
